美国放射学会与国家肾脏基金会关于肾病患者使用静脉碘对比剂的共识声明
美国放射学会与国家肾脏基金会发布共识声明,指出静脉碘对比剂相关急性肾损伤风险被高估,主因历史研究缺乏对照组难以区分对比剂所致与巧合发生的肾损伤。对于急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2且未维持透析者,推荐静脉生理盐水预防;估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者可由临床医生酌情考虑预防。
要点
- 静脉碘对比剂相关急性肾损伤的真实风险在严重肾病中仍不确定。
- 急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2且未透析者推荐静脉生理盐水预防。
- 估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者可由临床医生酌情考虑预防。
诊断标准与关键数值
- 急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2且未维持透析者,推荐静脉生理盐水预防。
- 估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者,可由临床医生酌情考虑静脉生理盐水预防。
临床应用与阅片要点
- 对急性肾损伤或估算肾小球滤过率低于30 mL/min/1.73 m2且未维持透析者,推荐静脉生理盐水预防。
- 对估算肾小球滤过率30-44 mL/min/1.73 m2的高危患者,可由临床医生酌情考虑静脉生理盐水预防。
局限性
- 严重肾病患者对比剂所致急性肾损伤的真实风险仍不确定。
- 历史研究缺乏足够对照组以区分对比剂所致急性肾损伤与对比剂伴随的急性肾损伤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Intravenous iodinated contrast media are commonly used with CT to evaluate disease and to determine treatment response. The risk of acute kidney injury (AKI) developing in patients with reduced kidney function following exposure to intravenous iodinated contrast media has been overstated. This is due primarily to historic lack of control groups sufficient to separate contrast-induced AKI (CI-AKI; ie, AKI caused by contrast media administration) from contrast-associated AKI (CA-AKI; ie, AKI coincident to contrast media administration). Although the true risk of CI-AKI remains uncertain for patients with severe kidney disease, prophylaxis with intravenous normal saline is indicated for patients who have AKI or an estimated glomerular filtration rate less than 30 mL/min/1.73 m2 who are not undergoing maintenance dialysis. In individual high-risk circumstances, prophylaxis may be considered in patients with an estimated glomerular filtration rate of 30-44 mL/min/1.73 m2 at the discretion of the ordering clinician. This article is a simultaneous joint publication in Radiology and Kidney Medicine. The articles are identical except for stylistic changes in keeping with each journal's style. Either version may be used in citing this article.
引用
- Davenport MS, Perazella MA, Yee J, et al. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020. PMID: 31961246. doi:10.1148/radiol.2019192094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。